As of 2025-12-22, the Relative Valuation of ANI Pharmaceuticals Inc (ANIP) is 82.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 82.85 USD, the upside of ANI Pharmaceuticals Inc based on Relative Valuation is 0.0%.
The range of the Relative Valuation is 54.42 - 84.18 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.1x - 46.6x | 45.9x |
| Forward P/E multiples | 35.5x - 46.6x | 45.9x |
| Fair Price | 54.42 - 84.18 | 82.88 |
| Upside | -34.3% - 1.6% | 0.0% |
| Date | P/E |
| 2025-12-19 | 45.89 |
| 2025-12-18 | 45.87 |
| 2025-12-17 | 45.61 |
| 2025-12-16 | 44.92 |
| 2025-12-15 | 45.14 |
| 2025-12-12 | 44.52 |
| 2025-12-11 | 45.49 |
| 2025-12-10 | 45.43 |
| 2025-12-09 | 45.23 |
| 2025-12-08 | 45.05 |
| 2025-12-05 | 45.29 |
| 2025-12-04 | 45.83 |
| 2025-12-03 | 45.79 |
| 2025-12-02 | 45.48 |
| 2025-12-01 | 46.78 |
| 2025-11-28 | 46.99 |
| 2025-11-26 | 46.72 |
| 2025-11-25 | 46.09 |
| 2025-11-24 | 44.85 |
| 2025-11-21 | 44.15 |
| 2025-11-20 | 43.49 |
| 2025-11-19 | 44.49 |
| 2025-11-18 | 44.90 |
| 2025-11-17 | 45.40 |
| 2025-11-14 | 46.53 |
| 2025-11-13 | 46.83 |
| 2025-11-12 | 48.33 |
| 2025-11-11 | 49.04 |
| 2025-11-10 | 49.25 |
| 2025-11-07 | 50.08 |
| 2025-11-06 | 49.97 |
| 2025-11-05 | 51.30 |
| 2025-11-04 | 52.33 |
| 2025-11-03 | 52.09 |
| 2025-10-31 | 50.18 |
| 2025-10-30 | 50.91 |
| 2025-10-29 | 51.08 |
| 2025-10-28 | 51.67 |
| 2025-10-27 | 51.43 |
| 2025-10-24 | 52.19 |
| 2025-10-23 | 52.56 |
| 2025-10-22 | 51.93 |
| 2025-10-21 | 52.83 |
| 2025-10-20 | 52.68 |
| 2025-10-17 | 52.50 |
| 2025-10-16 | 50.93 |
| 2025-10-15 | 49.90 |
| 2025-10-14 | 49.15 |
| 2025-10-13 | 49.08 |
| 2025-10-10 | 49.73 |